WallStreetZenWallStreetZen

NASDAQ: GCTK
Glucotrack Inc Stock

Open Broker Account
$1.62+0.00 (+0%)
Updated Dec 9, 2022
GCTK Price
$1.62
Fair Value Price
$1.62
Market Cap
$25.07M
52 Week Low
$1.50
52 Week High
$4.85
P/E
-5.59x
P/B
10.65x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$4.65M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.49
Operating Cash Flow
-$4M
Beta
0.06
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

GCTK Overview

GlucoTrack, Inc., a medical device company, develops non-invasive glucose monitoring devices for people suffering from diabetes and pre-diabetics. Known as Integrity Applications, Inc. until 2021/11, GlucoTrack was founded in 2001 and is based in Or Yehuda, Israel.

Zen Score

Industry Average (33)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how GCTK scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

GCTK ($1.62) is undervalued by 0.01% relative to our estimate of its Fair Value price of $1.62 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
GCTK ($1.62) is not significantly undervalued (0.01%) relative to our estimate of its Fair Value price of $1.62 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
GCTK is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more GCTK due diligence checks available for Premium users.

Be the first to know about important GCTK news, forecast changes, insider trades & much more!

GCTK News

Valuation

GCTK fair value

Fair Value of GCTK stock based on Discounted Cash Flow (DCF)
Price
$1.62
Fair Value
$1.62
Undervalued by
0.01%
GCTK ($1.62) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
GCTK ($1.62) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
GCTK is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

GCTK price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-5.59x
Industry
-74.44x
Market
21.21x

GCTK price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
10.65x
Industry
3.56x
GCTK is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

GCTK's financial health

Profit margin

Revenue
$0.0
Net Income
-$928.0k
Profit Margin
0%
GCTK's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$3.5M
Liabilities
$1.2M
Debt to equity
0.49
GCTK's short-term assets ($3.43M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
GCTK's short-term assets ($3.43M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
GCTK's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
GCTK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$608.0k
Investing
$0.0
Financing
$0.0
GCTK's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

GCTK vs Medical Stocks

TickerMarket Cap1d %P/EP/B
GCTK$25.07M0.00%-5.59x10.65x
ECOR$22.42M+15.38%-1.02x1.01x
EKSO$19.45M+0.68%-1.29x0.68x
POAI$31.97M+1.50%-1.07x1.08x
MBOT$32.98M+1.95%-2.12x5.96x

Glucotrack Stock FAQ

What is Glucotrack's quote symbol?

NASDAQ: GCTK) Glucotrack trades on the NASDAQ under the ticker symbol GCTK. Glucotrack stock quotes can also be displayed as NASDAQ: GCTK.

If you're new to stock investing, here's how to buy Glucotrack stock.

What is the 52 week high and low for Glucotrack (NASDAQ: GCTK)?

(NASDAQ: GCTK) Glucotrack's 52-week high was $4.85, and its 52-week low was $1.50. It is currently -66.6% from its 52-week high and 8% from its 52-week low.

How much is Glucotrack stock worth today?

(NASDAQ: GCTK) Glucotrack currently has 15,476,665 outstanding shares. With Glucotrack stock trading at $1.62 per share, the total value of Glucotrack stock (market capitalization) is $25.07M.

Glucotrack stock was originally listed at a price of $81.25 in Apr 25, 2013. If you had invested in Glucotrack stock at $81.25, your return over the last 9 years would have been -98.01%, for an annualized return of -35.27% (not including any dividends or dividend reinvestments).

How much is Glucotrack's stock price per share?

(NASDAQ: GCTK) Glucotrack stock price per share is $1.62 today (as of Dec 9, 2022).

What is Glucotrack's Market Cap?

(NASDAQ: GCTK) Glucotrack's market cap is $25.07M, as of Dec 10, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Glucotrack's market cap is calculated by multiplying GCTK's current stock price of $1.62 by GCTK's total outstanding shares of 15,476,665.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.